Literature DB >> 9562566

Earliest steps in primary tumor formation and micrometastasis resolved with histochemical markers of gene-tagged tumor cells.

L A Culp1, W Lin, N R Kleinman, K L O'Connor, R Lechner.   

Abstract

To facilitate detection of tumor cells at the highest resolution in any organ in athymic nude mouse model systems, a histochemical marker gene [bacterial lacZ or human placental alkaline phosphatase (ALP)] was transfected into specified transformed/tumor cells (fibrosarcoma or neuroblastoma). The fates of tumor cells were followed qualitatively and quantitatively by histochemical staining of whole organs or organ sections. Primary tumors developed initially via formation of "curly-haired" complexes of cells in the subcutis or dermis, followed by division of a large fraction of cells. When two tumor classes were mixed before injection, outgrowth occurred in regional concentrations of the primary tumor. Blood microvessels were detectable within 72 hr of injection, growing into tumor regions. iv injection routinely yielded multicellular foci in the lungs within minutes as precursors of experimental metastases. Micrometastasis was further resolved with cells "inactivated" by different treatments and by co-injection of two different tagged cell types. These approaches using different histochemical marker genes to "tag" different tumor cell classes, along with more advanced molecular biological approaches, permit us to characterize gene expression and its reversibility during the earliest stages of primary tumor formation and micrometastasis to virtually any organ in the recipient animal.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9562566     DOI: 10.1177/002215549804600501

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  8 in total

1.  Differential experimental micrometastasis to lung, liver, and bone with lacZ-tagged CWR22R prostate carcinoma cells.

Authors:  Julianne L Holleran; Carson J Miller; Nancy L Edgehouse; Theresa P Pretlow; Lloyd A Culp
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

Review 2.  Motivation for Launching a Cancer Metastasis Inhibition (CMI) Program.

Authors:  Jill M Pulley; Rebecca N Jerome; Martin L Ogletree; Gordon R Bernard; Robert R Lavieri; Nicole M Zaleski; Charles C Hong; Jana K Shirey-Rice; Carlos L Arteaga; Ingrid A Mayer; Kenneth J Holroyd; Rebecca S Cook
Journal:  Target Oncol       Date:  2018-02       Impact factor: 4.493

3.  A fluorescent orthotopic mouse model for reliable measurement and genetic modulation of human neuroblastoma metastasis.

Authors:  K Cecilia Henriksson; Malin A E Almgren; Ralph Thurlow; Nissi M Varki; Christina L Chang
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

4.  Redistribution of fibroblasts and macrophages as micrometastases develop into established liver metastases.

Authors:  Nobuaki Higashi; Hideki Ishii; Takeshi Fujiwara; Megumi Morimoto-Tomita; Tatsuro Irimura
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

5.  Detection of micrometastasis of gastric carcinoma in peripheral blood circulation.

Authors:  Xi-Mei Chen; Guo-Yu Chen; Zhi-Rong Wang; Feng-Shang Zhu; Xiao-Lei Wang; Xia Zhang
Journal:  World J Gastroenterol       Date:  2004-03-15       Impact factor: 5.742

Review 6.  Investigation of Metastasis-Related Genes: A Rat Model Mimicking Liver Metastasis of Colorectal Carcinoma.

Authors:  Hassan Adwan; Rania Georges; Asim Pervaiz; Martin R Berger
Journal:  Front Oncol       Date:  2017-07-18       Impact factor: 6.244

7.  Luciferase Expression Allows Bioluminescence Imaging But Imposes Limitations on the Orthotopic Mouse (4T1) Model of Breast Cancer.

Authors:  V P Baklaushev; A Kilpeläinen; S Petkov; M A Abakumov; N F Grinenko; G M Yusubalieva; A A Latanova; I L Gubskiy; F G Zabozlaev; E S Starodubova; T O Abakumova; M G Isaguliants; V P Chekhonin
Journal:  Sci Rep       Date:  2017-08-10       Impact factor: 4.379

8.  Aberrant Cytokeratin 20 mRNA Expression in Peripheral Blood and Lymph Nodes Indicates Micrometastasis and Poor Prognosis in Patients With Gastric Carcinoma.

Authors:  Xiaolan You; Yuanjie Wang; Jian Wu; Qinghong Liu; Dehu Chen; Dong Tang; Daorong Wang
Journal:  Technol Cancer Res Treat       Date:  2019-01-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.